These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11834429)

  • 1. Ghrelin drives GH secretion during fasting in man.
    Muller AF; Lamberts SW; Janssen JA; Hofland LJ; Koetsveld PV; Bidlingmaier M; Strasburger CJ; Ghigo E; Van der Lely AJ
    Eur J Endocrinol; 2002 Feb; 146(2):203-7. PubMed ID: 11834429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance.
    Muller AF; Janssen JA; Hofland LJ; Lamberts SW; Bidlingmaier M; Strasburger CJ; van der Lely AJ
    J Clin Endocrinol Metab; 2001 Feb; 86(2):590-3. PubMed ID: 11158013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
    Muller AF; Janssen JA; Lamberts SW; Bidlingmaier M; Strasburger CJ; Hofland L; van der Lely AJ
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects.
    Moller L; Norrelund H; Jessen N; Flyvbjerg A; Pedersen SB; Gaylinn BD; Liu J; Thorner MO; Moller N; Lunde Jorgensen JO
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4524-32. PubMed ID: 19820031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.
    Veldhuis JD; Bidlingmaier M; Anderson SM; Wu Z; Strasburger CJ
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3304-10. PubMed ID: 11443205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of free fatty acids, growth hormone and growth hormone receptor blockade on serum ghrelin levels in humans.
    Gormsen LC; Nielsen C; Gjedsted J; Gjedde S; Vestergaard ET; Christiansen JS; Jørgensen JO; Møller N
    Clin Endocrinol (Oxf); 2007 May; 66(5):641-5. PubMed ID: 17492951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects.
    Espelund U; Hansen TK; Højlund K; Beck-Nielsen H; Clausen JT; Hansen BS; Orskov H; Jørgensen JO; Frystyk J
    J Clin Endocrinol Metab; 2005 Feb; 90(2):741-6. PubMed ID: 15522942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.
    Broglio F; Arvat E; Benso A; Gottero C; Muccioli G; Papotti M; van der Lely AJ; Deghenghi R; Ghigo E
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5083-6. PubMed ID: 11600590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone.
    Luque RM; Park S; Kineman RD
    Endocrinology; 2007 Jan; 148(1):300-9. PubMed ID: 17038558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal changes in endogenous ghrelin and growth hormone during fasting in healthy women.
    Koutkia P; Schurgin S; Berry J; Breu J; Lee BS; Klibanski A; Grinspoon S
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E814-22. PubMed ID: 15972272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effect of pegvisomant on cardiovascular risk markers in healthy men: implications for the pathogenesis of atherosclerosis in GH deficiency.
    Muller AF; Leebeek FW; Janssen JA; Lamberts SW; Hofland L; van der Lely AJ
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5165-71. PubMed ID: 11701672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH does not modulate the early fasting-induced release of free fatty acids in mice.
    Steyn FJ; Leong JW; Huang L; Tan HY; Xie TY; Nelson C; Waters MJ; Veldhuis JD; Epelbaum J; Chen C
    Endocrinology; 2012 Jan; 153(1):273-82. PubMed ID: 22109889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
    Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern.
    Natalucci G; Riedl S; Gleiss A; Zidek T; Frisch H
    Eur J Endocrinol; 2005 Jun; 152(6):845-50. PubMed ID: 15941923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
    Janssen JA; van der Toorn FM; Hofland LJ; van Koetsveld P; Broglio F; Ghigo E; Lamberts SW; Jan van der Lely A
    Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.